Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Don’t Push Mayo To The Side, Hikma Urges Top US Court
Jan 07 2019
•
By
Aidan Fry
The US Federal Circuit's ruling last year on iloperidone chips away at Supreme Court precedents on patent eligibility, Hikma argues • Source: Shutterstock
More from Legal & IP
More from Generics Bulletin